IMM
Click for more information
20.3% 35.5¢ immutep limited

Ann: Prima initiates phase IIb study in metastatic breast cancer, page-15

  1. ST
    3,037 Posts.
    clock Created with Sketch.
    30/12/15
    11:16
    Post #: 16700340
    Thanks guys.

    Seems in the short term, holders in US are awaiting for a big pharma deal.

    Does this relate to partnering for the trials and subsequent funding or for some other purpose?
    PRR Price at posting: 5.1¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

OBM Ora Banda sees FY26 gold output jumping to 150Koz/pa following key approval for Sand King
right-arrow Created with Sketch.
I88 Infini Resources announces exceptionally high-grade uranium soil assay results
right-arrow Created with Sketch.
NEWS What matters for FY25: Investment; interest rates; inflation & elections
right-arrow Created with Sketch.
AUG Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree
right-arrow Created with Sketch.
TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
right-arrow Created with Sketch.
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
35.5¢ 		Change
0.060(20.3%) 		Mkt cap ! $515.6M
Open High Low Value Volume
36.0¢ 37.5¢ 33.5¢ $6.427M 18.03M

Buyers (Bids)

No. Vol. Price($)
1 50000 35.5¢
 

Sellers (Offers)

Price($) Vol. No.
36.0¢ 133736 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.